NCAPD2 serves as a potential prognostic biomarker for lung adenocarcinoma and promotes cell proliferation, migration, invasion and cell cycle in vitro
Oncology Research · 2024
DOI: 10.32604/or.2024.047490 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research, 2024. Verfasst von Peiling Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China. Hauptthemen laut MEDLINE: Cell Proliferation, Adenocarcinoma of Lung, Cell Movement, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
Zitieren
APA
Wu, P., Zhao, L., Zhang, H., Lou, Y., Chen, D., Xue, S., Liu, X., & Jiang, H. (2024). NCAPD2 serves as a potential prognostic biomarker for lung adenocarcinoma and promotes cell proliferation, migration, invasion and cell cycle in vitro. Oncology Research. https://doi.org/10.32604/or.2024.047490
Vancouver
Wu P, Zhao L, Zhang H, Lou Y, Chen D, Xue S, et al. NCAPD2 serves as a potential prognostic biomarker for lung adenocarcinoma and promotes cell proliferation, migration, invasion and cell cycle in vitro. Oncology Research. 2024. doi:10.32604/or.2024.047490
BibTeX
@article{Wu2024,
author = {Wu, Peiling and Zhao, Lifang and Zhang, Hongyan and Lou, Yueyan and Chen, Dongfang and Xue, Shan and Liu, Xueqing and Jiang, Handong},
title = {NCAPD2 serves as a potential prognostic biomarker for lung adenocarcinoma and promotes cell proliferation, migration, invasion and cell cycle in vitro},
journal = {Oncology Research},
year = {2024},
doi = {10.32604/or.2024.047490}
}
EUVIMED